5.2 Fluid-Regulation & Thyroid Disorders

5.2 Fluid-Regulation & Thyroid Disorders

This section covers two pairs of opposite disorders that the PCCN exam loves to contrast: SIADH versus diabetes insipidus (both disrupt water balance through antidiuretic hormone), and thyroid storm versus myxedema coma (both are life-threatening extremes of thyroid function).

Syndrome of Inappropriate Antidiuretic Hormone (SIADH)

SIADH occurs when excess antidiuretic hormone (ADH/vasopressin) causes the kidneys to reabsorb water in excess of solute. The result is a dilutional, euvolemic hyponatremia: serum sodium and serum osmolality fall (serum osmolality typically <275 mOsm/kg), while urine becomes inappropriately concentrated (urine osmolality exceeds serum osmolality; urine specific gravity is elevated, often >1.020). Because the excess water is intracellular rather than in the vascular space, patients are euvolemic — no edema, no signs of dehydration.

Common causes: ectopic ADH production (classically small cell lung cancer), CNS disorders (stroke, head trauma, meningitis), pulmonary disease (pneumonia, positive-pressure ventilation), medications (SSRIs, carbamazepine, certain chemotherapy agents), and physiologic stress, pain, or nausea.

Symptoms track the degree and speed of hyponatremia: headache, nausea, and lethargy progress to seizures, coma, and cerebral edema if sodium falls low or fast enough.

Treatment: fluid restriction (roughly 800–1,000 mL/day) is first-line for mild or chronic cases. For severe or symptomatic hyponatremia (seizures, coma), cautious hypertonic (3%) saline is used. Vasopressin receptor antagonists (tolvaptan, conivaptan) are options for refractory cases. Critical safety point: correct serum sodium slowly — no more than about 8–10 mEq/L in 24 hours — because overly rapid correction can cause osmotic demyelination syndrome (central pontine myelinolysis), a devastating and often permanent neurologic injury. Sodium levels should be monitored frequently (as often as every 2–4 hours) during active correction.

Diabetes Insipidus (DI)

DI is essentially the mirror image of SIADH: a deficiency of ADH effect causes the kidneys to excrete large volumes of dilute urine. Central DI results from inadequate ADH production (pituitary or hypothalamic injury from surgery, trauma, or tumor); nephrogenic DI results from renal insensitivity to ADH (lithium therapy, hypercalcemia, genetic causes).

Presentation: massive dilute urine output (often several liters/day, or well above 200–300 mL/hr), low urine specific gravity (<1.005) and low urine osmolality, with resulting hypernatremia and rising serum osmolality if free water intake cannot keep pace. An intact thirst mechanism produces severe thirst; an altered level of consciousness that prevents adequate oral intake can instead produce dangerous dehydration and hypovolemia.

Treatment: for central DI, give desmopressin (DDAVP), a synthetic ADH analog (intranasal, oral, or parenteral), and replace free water (oral or IV D5W) matched to urine output; monitor hourly intake/output, daily weights, and serum sodium trends closely. For nephrogenic DI, treat the underlying cause (discontinue lithium, correct hypercalcemia); paradoxically, thiazide diuretics and a low-sodium/low-protein diet can reduce urine volume.

DI is a frequent finding after neurosurgery, traumatic brain injury, or pituitary tumor resection, so the progressive care nurse should watch for a sudden increase in dilute urine output in these populations and trend serum sodium and osmolality closely — untreated DI after neurosurgery can produce dangerous hypernatremia within hours. Conversely, a "triple phase" response (transient DI, followed by a SIADH-like phase, followed by permanent DI) can occur after pituitary surgery, so urine output and sodium trends should never be assumed to be stable just because an initial DI phase has resolved.

Thyroid Storm

Thyroid storm is a life-threatening exacerbation of hyperthyroidism, usually triggered by infection, surgery, trauma, an iodine load, or abrupt discontinuation of antithyroid medication. Presentation includes severe tachycardia and dysrhythmias (atrial fibrillation is common), hyperthermia (often above 101°F/38.3°C and sometimes exceeding 104°F), agitation or delirium progressing to coma, GI symptoms (nausea, vomiting, diarrhea), and high-output heart failure.

Treatment: beta-blockers (propranolol is preferred because it also blocks peripheral conversion of T4 to T3), thionamides (propylthiouracil or methimazole) to block new hormone synthesis, iodine solution to block hormone release — given only after the thionamide, since iodine given first can fuel additional new hormone synthesis — corticosteroids (block T4-to-T3 conversion and cover possible relative adrenal insufficiency), active cooling measures, and treatment of the precipitating cause.

Myxedema Coma

Myxedema coma is the life-threatening decompensated extreme of hypothyroidism. Presentation includes hypothermia, bradycardia, hypotension, hypoventilation with hypercapnic respiratory failure, altered mental status or coma, dilutional hyponatremia (an SIADH-like mechanism), and hypoglycemia.

Treatment: IV levothyroxine (T4), sometimes with liothyronine (T3); IV corticosteroids given before or with thyroid hormone replacement (concurrent adrenal insufficiency is common and must be covered first); passive rewarming rather than rapid active rewarming, which can cause vasodilation and cardiovascular collapse; ventilatory support as needed; and treatment of the precipitating factor (infection, cold exposure, sedative use, MI, or stroke).

Both crises are clinical diagnoses supported by, but not dependent on, formal scoring tools (such as the Burch-Wartofsky Point Scale for thyroid storm); progressive care nurses should treat a strongly suspicious presentation immediately rather than waiting on a confirmatory free T4/TSH result, since either crisis can decompensate to cardiac arrest within hours if untreated.